AXA S.A., FR0000120628

UBS raises target for AXA stock from EUR 51 to EUR 55

Published on 10/21/2026 at 10:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

AXA stock costs EUR 43.06 on October 21, 2026, above the Xetra close. UBS raised its target to EUR 55 on October 14.

Analyst target and operating results

UBS raised its AXA target from EUR 51 to EUR 55 on October 14, 2026.
AXA delivered 8 percent underlying earnings per share growth in the first half of 2026 and held its Solvency II ratio at 218 percent.
AXA stock trades at EUR 43.06 at 10:13 a.m. CEST at Lang & Schwarz on October 21, 2026, 0.47 percent above the Xetra close of October 20, 2026.

Bunte Comic-Illustration eines Handschlags zwischen Berater und Kunde im Pop-Art-Stil — Pop-Art-Comic mit Handschlag und Sprechblase SAFE symbolisiert Sicherheitsversprechen von AXA S.A. (FR0000120628), Illustration mit AI erstellt.

AXA stock (ISIN FR0000120628) was trading at EUR 43.06 at Lang & Schwarz on October 21, 2026 at 10:13 a.m. CEST, up 0.47 percent from the EUR 42.86 Xetra close of October 20, 2026. The latest analyst move came from UBS, which raised its AXA target from EUR 51 to EUR 55 on October 14, 2026, while keeping a Buy view, according to Ideal Investisseur.

Target rises as results hold

The UBS target implies a 27.69 percent increase from the Lang & Schwarz price, calculated from EUR 43.06 to EUR 55.00. The analyst change therefore puts AXA's valuation discussion above the immediate daily move, which remains below the 1 percent threshold.

AXA's first half 2026 results provide the operating backdrop. In the earnings call dated July 31, 2026, management reported 8 percent underlying earnings per share growth, 9 percent growth in underlying earnings excluding AXA IM and a Solvency II ratio of 218 percent, according to Yahoo Finance.

Three dates frame the story

On July 31, 2026, AXA reported its first half results with 8 percent underlying earnings per share growth. On October 1, 2026, the insurer executed a share repurchase agreement worth a maximum EUR 470.80 million to offset dilution from Shareplan 2026, according to AXA. On October 14, 2026, UBS moved its target from EUR 51 to EUR 55 while retaining Buy, as reported by Ideal Investisseur.

What comes next for AXA?

The next scheduled operating update is the publication of activity indicators for the first nine months of 2026 on October 29, 2026, according to AXA. The same date is also the deadline stated for the buyback transactions linked to the employee offering, giving investors two company-specific milestones to compare with the new analyst target.

Stock holds near its yearly range

AXA's primary listing is on Euronext Paris under ticker CS, and the company is a CAC 40 constituent. The primary-market reference showed a 52-week range of EUR 36.55 to EUR 45.66 in the source reviewed, leaving the Lang & Schwarz price EUR 2.60 below the high, or 5.70 percent below that level. The figures frame the UBS target as a test of earnings delivery rather than a short-term trading signal.

AXA was trading at EUR 43.06 at Lang & Schwarz on October 21, 2026 at 10:13 a.m. CEST, 0.47 percent above the Xetra close of October 20, 2026 at EUR 42.86. The further course of trading is shown by the continuously updated real-time quote of AXA stock.